Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in Critically Ill Patients Receiving Continuous Infusion Monotherapy for Treating Documented Gram-Negative BSIs and/or VAP

• मुख्य लेखकों: Milo Gatti (लेखक), Matteo Rinaldi (लेखक), Tommaso Tonetti (लेखक), Antonio Siniscalchi (लेखक), Pierluigi Viale (लेखक), Federico Pea (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: MDPI AG, 2024-03-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

(1) Background: The advantage of using carbapenems over beta-lactam/beta-lactamase inhibitor combinations in critically ill septic patients still remains a debated issue. We aimed to assess the comparative impact of an optimized pharmacokinetic/pharmacodynamic (PK/PD) target attainment of piperacill...